GM Crop Results Spun Both Ways

UK's landmark trials misrepresented by industry and campaigners, Royal Society says.

Written byStephen Pincock
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Campaigners opposed to the release of genetically modified (GM) crops and the GM industry have both misrepresented the results of Britain's farm scale evaluations (FSEs) of such crops, which were published last month, according to the president of the Royal Society.

Robert May said today (November 25) the experiments demonstrated that GM crops “may be applied in ways that are better for biodiversity than conventional practices, or alternatively may be used to further intensify agriculture with a corresponding negative effect on farmland wildlife.”

He was speaking ahead of a meeting of the Advisory Committee on Releases to the Environment (ACRE) about the research, to which the Royal Society has made a submission.

“To generalize and declare 'all GM is bad' or 'all GM is good' for the environment as a result of these experiments is a gross oversimplification, but statements from both sides in the GM propaganda war have claimed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies